[2-(diphenylmethoxy)ethyl]dimethylamine hydrochloride, 98.0%, 25g

Ethyl 2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinate, 95.0%, 250mg

2-Chloro-6-methyl-N-phenylbenzamide, 95.0%, 100g

3-(Benzo[d]thiazol-2-yl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-amine, 95.0%, 1g

2-Chloro-5-nitrocinnamic acid, 97.0%, 25g

iScope IS.1153-PLPHi Triocular with Plan phase IOS objectives and Rackless cross table (infinity)

(4'-FLUORO-5'-ISOPROPYL-2'-METHOXY-4-TRIFLUOROMETHYL-BIPHENYL-2-YL)METHANOL, 95.0%, 250mg

4-(4-Chlorophenyl)oxan-4-amine, 98+%, 250mg

(S)-4-(Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)morpholine, 98.0%, 1g

N-(1-Isopropoxyethyl)acetamide>93.0%(GC)25g

4-[(2-methylhydrazin-1-yl)methyl]-N-(propan-2-yl)benzamide hydrochloride, 97.0%, 25g

3-bromo-6-methoxyquinolin-4-ol, 95.0%, 250mg

3-Formyl-5-methoxyindole, 98.0%, 25g